Abnormal serotonin-glutamate interaction in prefrontal cortex (PFC) is implicated in the pathophysiology of many mental disorders, including schizophrenia and depression. However, the mechanisms by which this interaction occurs remain unclear. Our previous study has shown that activation of 5-HT 1A
Serotonin (5-HT)2 is a key neuromodulator mediating diverse cognitive and emotional functions in the central nervous system (1). The pleiotropic functions of serotonin are afforded by the concerted actions of multiple 5-HT receptor subtypes, 5-HT 1 -to 5-HT 7 (2, 3). Mice lacking 5-HT receptors exhibit phenotypes ranging from increased anxiety (4), to elevated aggression (5), to antidepressant-like behaviors (6). One of the major targets of serotonin is prefrontal cortex (PFC), a crucial brain region controlling emotion and cognition (7,8). Several lines of evidence have shown that 5-HT 1A and 5-HT 2A receptors, which are abundantly co-expressed in most of PFC pyramidal neurons (9), often have opposing actions on common substrates. For instance, activation of 5-HT 1A receptors results in neuronal inhibition by increasing potassium currents (10) and decreasing calcium currents (11). In contrast, 5-HT 2A receptor stimulation leads to neuronal excitation by suppressing potassium currents (2) and enhancing pre-synaptic glutamate release (12). Moreover, elevated 5-HT 1A receptors and reduced 5-HT 2A receptors are found in PFC of schizophrenia patients (13,14), suggesting that the levels of 5-HT 1A and 5-HT 2A receptors are differentially altered in diseased states.One of the potential cellular targets of 5-HT receptors involved in cognitive and emotional control is the NMDA-type glutamate receptor, a ligand-gated ion channel that has been implicated in the pathophysiology of mental disorders (15). NMDAR hypofunction caused by systemic administration of non-competitive NMDAR antagonists or knockdown of NMDAR expression produces schizophrenia-like behavioral symptoms (16 -18). Moreover, it has been found that the expression of NMDARs is reduced in postmortem brains of depressed patients (19), and chronic antidepressant treatment enhances NMDAR levels in mouse brains (20). Our previous study has shown that activation of 5-HT 1A receptors suppresses NMDAR channel function in PFC pyramidal neurons (21). It remains unknown whether 5-HT 2A receptor activation has any impact on the 5-HT 1A -NMDAR interaction.